Pharmafile Logo
Pharmafocus logo
Advanced Search

michael bonney

Showing 2 posts of 2 posts found.

Former Cubist chief executive Michael Bonney to chair board at Alnylam

December 22, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Alnylam, David Pyott, michael bonney

Michael Bonney, current board member and former chief executive of Cubist Pharmaceuticals, has been appointed as chairman of Alnylam Pharmaceuticals …

Appointment
michael_w

Celgene appoints former Cubist chief executive

April 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, cubist, michael bonney

Celgene has elected pharma veteran Michael Bonney to join its board of directors. Bonney served as chief executive and board …

Appointment

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023